Enliven Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
USD
29.42
2.43 (9.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
9%
-1.23%
1W
11.23%
-2.45%
1M
94.32%
-1.5%
YTD
91.04%
-0.69%
1Y
30.93%
12.16%
3Y
455.09%
64.35%
5Y
-47.84%
74.91%
10Y
-47.84%
261.61%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
60.77%
0%
60.77%
6 Months
56.16%
0%
56.16%
1 Year
30.93%
0%
30.93%
2 Years
87.03%
0%
87.03%
3 Years
455.09%
0%
455.09%
4 Years
461.45%
0%
461.45%
5 Years
-47.84%
0%
-47.84%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary